Parliamentary questions

Questions

TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work

Browse the questions

Clear

Showing questions asked by Ken O'Flynn .

3,835 questions match, newest first.

Ken O'Flynn Written 14 May 2026 · to Health
765. Deputy Ken O'Flynn asked the Minister for Health whether the absence of structured national monitoring systems for gender-related healthcare services for minors has been discussed with HIQA, the Mental Health Commission or any other oversight body. [36392/26]
Ken O'Flynn Written 14 May 2026 · to Health
773. Deputy Ken O'Flynn asked the Minister for Health whether dispensing trends for salbutamol nebules are monitored as part of winter preparedness or respiratory surveillance planning. [36448/26]
Ken O'Flynn Written 14 May 2026 · to Health
774. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains regional prescribing trend analysis for nebulised bronchodilator medications; and if so, to provide the latest available data. [36449/26]
Ken O'Flynn Written 14 May 2026 · to Health
775. Deputy Ken O'Flynn asked the Minister for Health whether any review has been undertaken into the drivers of variation in average reimbursement cost per salbutamol nebule item under the General Medical Services scheme since 2024. [36450/26]
Ken O'Flynn Written 14 May 2026 · to Health
776. Deputy Ken O'Flynn asked the Minister for Health whether PCRS reimbursement prescribing data is integrated with any national respiratory disease monitoring or forecasting systems. [36451/26]
Ken O'Flynn Written 14 May 2026 · to Health
777. Deputy Ken O'Flynn asked the Minister for Health whether the Department has assessed the extent to which high-frequency salbutamol dispensing may indicate gaps in preventative asthma or COPD management in primary care. [36452/26]
Ken O'Flynn Written 14 May 2026 · to Health
778. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has identified any supply-chain, pricing or reimbursement pressures affecting nebulised respiratory medications since 2024. [36453/26]
Ken O'Flynn Written 12 May 2026 · to Health
1036. Deputy Ken O'Flynn asked the Minister for Health the total agency staffing expenditure within the public Health Service to date in 2026, broken down by HSE health region, staff category, and service area; and if she will make a statement on the matter. [34121/26]
Ken O'Flynn Written 12 May 2026 · to Health
1037. Deputy Ken O'Flynn asked the Minister for Health the specific annual savings target set by the HSE for agency staffing expenditure in 2025 and 2026; the savings achieved to date; and if she will make a statement on the matter. [34122/26]
Ken O'Flynn Written 12 May 2026 · to Health
1038. Deputy Ken O'Flynn asked the Minister for Health the number of agency staff converted to direct HSE employment under the July 2025 agency conversion framework, broken down by HSE health region and staff category [34123/26]
Ken O'Flynn Written 12 May 2026 · to Health
1039. Deputy Ken O'Flynn asked the Minister for Health the reason maintenance and technical agency staffing expenditure increased from €12.4 million in 2024 to €68.2 million in 2025; whether this increase has been reviewed by the HSE or her Department; and if she will make a statement on the matter. [34124/26]
Ken O'Flynn Written 12 May 2026 · to Health
1040. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records the reason for agency staffing expenditure by category, including vacancy cover, sick leave, maternity leave, surge activity, or unfilled recruitment; and if so, to provide the breakdown for 2024, 2025, and to date in 2026. [34125/26]
Ken O'Flynn Written 12 May 2026 · to Health
1047. Deputy Ken O'Flynn asked the Minister for Health the total expenditure on agency staffing across the public health service in 2025 and to date in 2026, broken down by Health Region and staff category; and the proportion of this spend directly attributable to vacancies as distinct from absence or activity demand. [34208/26]
Ken O'Flynn Written 12 May 2026 · to Health
1048. Deputy Ken O'Flynn asked the Minister for Health the vacancy rate, expressed as a percentage, across the public health service by staff category and Health Region as of the most recent reporting period; and the methodology used to calculate same. [34209/26]
Ken O'Flynn Written 12 May 2026 · to Health
1049. Deputy Ken O'Flynn asked the Minister for Health the number of whole-time equivalent posts currently recorded as "regional commissioning in progress" across each Health Region; the timeline for the allocation of these posts; and whether any of these posts relate to existing vacancies rather than new service developments. [34210/26]
Ken O'Flynn Written 12 May 2026 · to Health
1070. Deputy Ken O'Flynn asked the Minister for Health whether a cumulative or population-level public health risk assessment has been conducted in respect of repeated manganese exceedances in drinking water in Cork city since 2024; and if not, whether such an assessment will now be undertaken. [34482/26]
Ken O'Flynn Written 12 May 2026 · to Health
1071. Deputy Ken O'Flynn asked the Minister for Health the number of recorded manganese exceedances in Cork city drinking water since 2024, including duration, concentration levels, and estimated population exposure in each case. [34483/26]
Ken O'Flynn Written 12 May 2026 · to Health
1072. Deputy Ken O'Flynn asked the Minister for Health whether any specific risk assessment has been undertaken in respect of infants, bottle-fed babies, and young children in areas affected by manganese exceedances. [34484/26]
Ken O'Flynn Written 12 May 2026 · to Health
1073. Deputy Ken O'Flynn asked the Minister for Health to clarify which body holds primary responsibility for public health protection where repeated exceedances of drinking water contaminants occur; and the way in which accountability is coordinated between the HSE, Uisce Éireann, and the Environmental Protection Agency. [34485/26]
Ken O'Flynn Written 12 May 2026 · to Health
1074. Deputy Ken O'Flynn asked the Minister for Health whether the current reliance on World Health Organization guidance in respect of manganese exposure has been independently reviewed or adapted for Irish population conditions. [34486/26]
Ken O'Flynn Written 12 May 2026 · to Health
1079. Deputy Ken O'Flynn asked the Minister for Health whether she will establish a centralised reporting mechanism within the HSE to record all cases in which healthcare professionals are subject to criminal investigation for serious offences, including sexual offences; and if she will outline a timeline for its implementation. [34527/26]
Ken O'Flynn Written 12 May 2026 · to Health
1080. Deputy Ken O'Flynn asked the Minister for Health whether she has sought the outstanding data from the remaining HSE regions in respect of cases involving criminal investigation of healthcare staff since 2015; and when a complete national figure will be available. [34528/26]
Ken O'Flynn Written 12 May 2026 · to Health
1081. Deputy Ken O'Flynn asked the Minister for Health whether formal national criteria exist governing the suspension or reassignment of healthcare professionals subject to criminal investigation for serious offences; and if she will publish those criteria. [34529/26]
Ken O'Flynn Written 12 May 2026 · to Health
1082. Deputy Ken O'Flynn asked the Minister for Health what national oversight mechanisms are in place to ensure consistent application of precautionary measures across all HSE regions where healthcare staff are under criminal investigation. [34530/26]
Ken O'Flynn Written 12 May 2026 · to Health
1083. Deputy Ken O'Flynn asked the Minister for Health the estimated average cost to the State of an outpatient appointment that is classified as "did not attend"; the total estimated annual financial impact of such missed appointments in each of the years 2023, 2024 and 2025; and if she will make a statement on the matter. [34531/26]